Browse Complete Report For More Information @ http://bit.ly/2IsKcTU
Pertuzumab Market– Regional Analysis
On the basis of region, the global pertuzumab market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global pertuzumab market due to
increasing prevalence of breast cancer among women in the U.S. For instance, according to
American Cancer Society 2017, around 52,710 new cases of invasive breast cancer were
diagnosed in 2017 among women in the U.S. and around 40,610 women were expected to die
due to breast cancer in the U.S. in same year.
Furthermore, Asia Pacific is expected to witness significant growth in the global pertuzumab
market, owing to increasing awareness of breast cancer and its management. For instance, in
November 2016, India launched National Cancer Screening Program to increase awareness and
early detection of breast cancer. This framework aims to offer mechanism for effective screening
and management of common cancers.
Pertuzumab market – Competitive Analysis
Key players operating in the global pertuzumab market include, Halozyme Therapeutics, Inc.
and F. Hoffmann-La Roche Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com